-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WdyrpljwvKwqPxK+gqjAh/Jp1EFk5MiW9/OegiBwuP3qERfcy8lhqUJTefe8eV4P K6q2hZXDxB7l4NY5Qud87w== 0001079973-10-000735.txt : 20100630 0001079973-10-000735.hdr.sgml : 20100630 20100630183003 ACCESSION NUMBER: 0001079973-10-000735 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100628 FILED AS OF DATE: 20100630 DATE AS OF CHANGE: 20100630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Buckland Andrew J CENTRAL INDEX KEY: 0001332290 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14468 FILM NUMBER: 10928409 MAIL ADDRESS: STREET 1: 1725 GILLESPIE WAY CITY: EL CAJON STATE: CA ZIP: 92020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PURE BIOSCIENCE CENTRAL INDEX KEY: 0001006028 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890] IRS NUMBER: 330530289 STATE OF INCORPORATION: CA FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 1725 GILLESPIE WAY STREET 2: STE H CITY: EL CAJON STATE: CA ZIP: 92020 BUSINESS PHONE: 6195968600 MAIL ADDRESS: STREET 1: 1725 GILLESPIE WAY STREET 2: SUITE H CITY: EL CAJON STATE: CA ZIP: 92020 FORMER COMPANY: FORMER CONFORMED NAME: PURE BIOSCIENCES DATE OF NAME CHANGE: 20031029 FORMER COMPANY: FORMER CONFORMED NAME: INNOVATIVE MEDICAL SERVICES DATE OF NAME CHANGE: 19960122 4 1 pure_buckland4.xml X0303 4 2010-06-28 0 0001006028 PURE BIOSCIENCE PURE 0001332290 Buckland Andrew J 1725 GILLESPIE WAY EL CAJON CA 92020 0 1 0 0 Chief Financial Officer Common Stock 2010-06-28 4 M 0 141666 0.85 A 47609 D Common Stock 2010-06-28 4 S 0 40000 2.8563 D 47609 D Common Stock 2010-06-29 4 S 0 40000 2.5586 D 47609 D Common Stock 2010-06-30 4 S 0 20000 2.5317 D 47609 D Stock Option 0.85 2010-06-28 4 M 0 141666 0.00 D 2005-08-02 2010-08-02 Common Stock 141666 0 D Pursuant to Rule 10b-5 Plan Incorporates all transactions being reported on this Form 4. There are no other changes to previously reported derivative securities. /s/ Dennis Brovarone Attorny-in-Fact for Andrew J. Buckland 2010-06-30 -----END PRIVACY-ENHANCED MESSAGE-----